Realm Therapeutics

About:

Realm Tx is a clinical stage biopharmaceutical company passionately committed to leveraging its proprietary immunomodulatory technology

Website: http://www.realmtx.com/

Top Investors: OrbiMed, RA Capital Management, Biotechnology Value Fund, Abingworth, Polar Capital

Description:

Realm Therapeutics is a biopharmaceutical company passionately committed to leveraging its proprietary technologies to protect and improve the health of adults and children. The Company's drug development focus, utilizing its immunomodulatory formulations, is targeted initially on developing small molecule therapies in inflammatory diseases with potential application in dermatology and ophthalmology, and the potential for broad applicability across a number of other diseases.

Total Funding Amount:

$26M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Malvern, Pennsylvania, United States

Founded Date:

2006-01-01

Founders:

Number of Employees:

11-50

Last Funding Date:

2017-09-22

IPO Status:

Public

Industries:

© 2025 bioDAO.ai